Top Markets
Coin of the day
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Hisse Senetlerindeki Sıralama #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Hisse Fiyatı
$0.12164306
Son senkronizasyon: 2024-11-11
Piyasa Değeri
$38.53M
Değişim (1 gün)
-4.14%
Değişim (1 yıl)
0.00%
Ülke
AU
Ticaret PharmAust Limited (PAA)

Kategori

PharmAust Limited (PAA) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.12 - 2024-11-01

Gün sonu en düşük fiyat: $3.11 - 2001-10-01
PharmAust Limited için hisse fiyatı geçmişi: 2001 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2024 72.79%
2023 61.50%
2022 -33.17%
2021 -20.54%
2020 20.68%
2019 171.67%
2018 -30.35%
2017 4.90%
2016 -29.98%
2015 -55.93%
2014 -33.04%
2013 25.44%
2012 -54.31%
2011 -8.75%
2010 -46.71%
2009 152.12%
2008 -65.75%
2007 -55.38%
2006 -27.70%
2005 -34.70%
2004 20.98%
2003 69.43%
2002 -28.84%
2001 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$544.87 38.17%
US
$1.03K 56.37%
NL
$120.74 -14.98%
AU
$139.03 417.03%
US
$762.65 7.15%
CH